Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells

Abstract In estrogen-receptor-positive human breast cancer cell lines (MCF7, ZR75-1), estrogens specifically increase the secretion into the culture medium of a 52,000 Da (52K) glycoprotein and stimulate cell proliferation. The 52K protein has been purified to homogeneity using monoclonal antibodies and identified as the secreted precursor of a cathepsin Dbearing mannose-6-phosphatesignals. The secreted precursor 52K protein is mitogenic in vitro in estrogen-deprived MCF7 cells, can be taken up by these cells via mannose-6-phosphate receptors, and can degrade extracellular matrix and proteoglycans glycans following its auto-activation. The protease is also produced constitutively by ER-negative cell lines, and is inducible by tamoxifen in some antiestrogen-resistant variants. The corresponding cDNA has been cloned using N-terminal sequencing of the protein and monoclonal antibodies. Its complete sequencingindicates a strong homology with pro- cathepsin Dof normal tissues. Using a cDNA probe, the regulation of 52K cathepsin DmRNA by estrogens and antiestrogenshas been studied and chromosome localization determined by in situ hybridization. Clinical studies using both immunohistochemistry and immunoenzymatic assay of breast cancer cytosol have shown that the concentration of total cellular cathepsin D(52K + 48K + 34K) is related to the proliferation of mammary ducts and to the prognosis of breast cancer. Its cytosolic concentration in primary tumors of postmenopausal patients is correlated slightly with lymph node invasion and significantly with shorter disease-free intervals in a 6-year retrospective study with the Danish Breast Cancer Groups and Finsen Institute (S. Thorpe et al .). We propose that in addition to estrogen-induced growth factors and other proteases such as plasminogen activator and collagenases, pro- cathepsin Dmay play an important role in the growth and invasiveness of hormone-dependent and independent breast cancers. Moreover, this lysosomal protease appears to be useful as a tissue marker for predicting high-risk mastopathies and invasive breast cancers.